|
This site contains resources and articles for you to use when you are looking
for information about mesothelioma cancer treatment. This site has articles,
links
to mesothelioma cancer treatment, information and news. In the future we will
have reviews of products that will help you make your decision easier with mesothelioma cancer treatment,
so you can save time
Mesothelioma Standard Treatment Options II
By: Govt
Standard treatment
options:
- Symptomatic treatment to include drainage of effusions,
chest tube
pleurodesis, or thoracoscopic pleurodesis.
- Palliative surgical resection
in selected patients.
- Palliative radiation therapy.
- Single-agent chemotherapy. Partial responses have been reported with
doxorubicin, epirubicin, mitomycin, cyclophosphamide, cisplatin, carboplatin,
and ifosfamide.
- Combination chemotherapy (under clinical evaluation). Information
about ongoing clinical trials is available from the NCI
Cancer.gov Website.
- Multimodality clinical trials.
- Intracavitary
therapy. Intrapleural or intraperitoneal administration
of
chemotherapeutic agents (e.g., cisplatin, mitomycin,
and cytarabine) has been
reported to produce transient
reduction in the size of tumor masses and
temporary control of effusions in small clinical studies. Additional
studies are needed to define the role of intra-cavitary therapy.
The safety and efficacy of pemetrexed, an antifolate, and
cisplatin in chemotherapy-n aive patients with malignant mesothelioma
who were not eligible for curative
surgery was demonstrated in a large phase III randomized trial. This
trial compared pemetrexed (500 mg/m2) and cisplatin (75
mg/m2 on day 1) with cisplatin alone (75 mg/m2 on day 1 intravenously every 21 days). A total of 456 patients
were enrolled: 226 patients received pemetrexed plus cisplatin and 222 patients
received cisplatin alone; 8 patients did not receive therapy.
After 117 patients had enrolled, folic acid and vitamin B12 were added to reduce toxic effects. Folic acid (350-1,000 µg orally)
was given daily, beginning 1 to 3 weeks before the first chemotherapy dose and
continuing daily until 1 to 3 weeks after treatment ended. A vi
tamin B12 injection (1,000 µg intramuscularly
) was administered 1 to 3 weeks before the first chemotherapy dose and was repeated
approximately every 9 weeks until treatment ended. Dexamethasone (4 mg) or
an equivalent corticosteroid
was administered orally twice daily for skin rash prophylaxis to all patients
1 day before,
on the day of, and 1 day after each pemetrexed dose.
In an analysis
of all patients who were randomized and treated, the combination of pemetrexed
and cisplatin was associated with a statistically significant improvement
in survival compared with cisplatin alone; the median
survivals were 1
2.1 versus 9.3 months, respectively (P=.020). The hazard ratio for death of
patients in the pemetrexed plus cisplatin arm versus those in the
control arm was 0.77. Median time to progression was significantly longer in the
pemetrexed plus cisplatin arm (5.7 months vs 3.9 months,
P=.001). This superiority in the combination arm was also demonstrated in the
vitamin supplemented subgroup. The median survivals were 13.3 and
10.0 months in the combination group and
cisplatin alone group, respectively (P=.051). The principal adverse
effects of the pemetrexed plus cisplatin regimen were myelosuppression, fatigue,
nausea, vomiting, and dyspnea. Mo....[MORE]
These are our featured resources and providers for mesothelioma cancer treatment. Feel free to check them out if you
are looking for resources and articles for you to
use. This list includes sites with articles, mesothelioma cancer treatment resources,
information and news.
Warning: fsockopen() [function.fsockopen]: php_network_getaddresses: getaddrinfo failed: Name or service not known in /home/mesothel/public_html/ppc/ppc_parser.php(1) : eval()'d code on line 160
Warning: fsockopen() [function.fsockopen]: unable to connect to adrevenue.findwhat.com:80 (php_network_getaddresses: getaddrinfo failed: Name or service not known) in /home/mesothel/public_html/ppc/ppc_parser.php(1) : eval()'d code on line 160
RevenuePilot.com - Premiere Online Advertising Network Attention Webmasters: Monetize your traffic. Get paid up to $2 for each unique click-through. No monthly limits, no conversion rates and no service charges. Receive your money by check or paypal anywhere in the world at no extra charge.
Admin report
Adrevenue :: Error #1: Connection error
| Mesothelioma Source - Resource for Asbestos Cancer Mesothelioma Source offers comprehensive information on types, stages and treatment of malignant mesothelioma ... What is mesothelioma? Mesothelioma is a form of cancer affecting the abdominal cavity, chest cavity, and the region ... Stages. Treatment Options. Clinical Trials. Cancer Centers ...
[see more on Mesothelioma Source - Resource for Asbestos Cancer]
|
| National Cancer Institute - Malignant Mesothelioma Treatment Expert-reviewed information summary about the treatment of malignant mesothelioma ... Malignant Mesothelioma (PDQ®): Treatment. Last Modified: 04/07/2005 ... of recovery) and treatment options. Malignant mesothelioma is a disease in which malignant (cancer) cells form in ...
[see more on National Cancer Institute - Malignant Mesothelioma Treatment]
|
| Mesothelioma & Asbestos Cancer Resource What is Mesothelioma? Mesothelioma is a rare disease caused as a result of malignant cancerous cells lining the patient's body cavities such as chest, abdominal region or the area surrounding the heart.
[see more on Mesothelioma & Asbestos Cancer Resource]
|
| Mesothelioma Alternative Cancer Treatment ... Mesothelioma Alternative Cancer Treatment. "My last 3 annual CT scans showed no growth of the cancer ... News. Books. Mesothelioma Alternative Cancer Treatment. The clinic has treated many ...
[see more on Mesothelioma Alternative Cancer Treatment]
|
| Mesothelioma Treatment and Legal Options - Early, Ludwick, Sweeney & Strauss Early, Ludwick, Sweeney & Strauss offers legal advice and treatment information for people diagnosed with mesothelioma and other asbestos related diseases. ... Effects For Mesothelioma Victims. FDA approves Alimta-Cisplatin Combination for treatment of Asbestos-Related Cancer ... be at risk to develop malignant mesothelioma. Learn More ...
[see more on Mesothelioma Treatment and Legal Options - Early, Ludwick, Sweeney & Strauss]
|
| MesoLink.org -- Your Link To Mesothelioma Information ... can provide important and in-depth Mesothelioma and cancer related information, and a legal guide to ... drug for the treatment of malignant pleural mesothelioma ( Altima ), which is a ...
[see more on MesoLink.org -- Your Link To Mesothelioma Information]
|
| Mesothelioma Cancer Treatment ... Mesothelioma. Malignant mesothelioma is a rare cancer that affects the cells lining various organs ... Because of the aggressive nature of malignant mesothelioma, treatment is difficult ...
[see more on Mesothelioma Cancer Treatment]
|
| Mesothelioma - Wikipedia, the free encyclopedia ... Mesothelioma is an uncommon form of cancer, usually associated with previous exposure to ... to help plan treatment. Mesothelioma is described as localized if the cancer is found only ...
[see more on Mesothelioma - Wikipedia, the free encyclopedia]
|
| Newsfeed brought especially to you....
|
|